Kodiak Sciences (KOD) Net Cash Flow (2017 - 2026)
Kodiak Sciences (KOD) reported Net Cash Flow of -$40.3 million for Q1 2026, down 38.01% on a YoY basis from -$65.1 million in Q1 2025, and down 129.26% quarter-over-quarter from $137.8 million in Q4 2025.
Kodiak Sciences (KOD) Net Cash Flow (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Net Cash Flow for 10 years, with the latest figure at -$40.3 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 38.01% year-over-year to -$40.3 million; the trailing twelve-month figure through Mar 2026 stood at $30.7 million (up 128.66% YoY), and the FY2025 full-year result was $41.8 million, up 135.55% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$40.3 million, down from $137.8 million in the prior quarter.
- The five-year high for Net Cash Flow was $137.8 million in Q4 2025, with the low at -$499.0 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$33.1 million across 5 years, with a median of -$29.8 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 1160.48% — and 2025, when it jumped 562.95%.
- Kodiak Sciences' Net Cash Flow stood at $12.0 million in 2022, then sank by 602.22% to -$60.2 million in 2023, then surged by 50.51% to -$29.8 million in 2024, then jumped by 562.95% to $137.8 million in 2025, then tumbled by 129.26% to -$40.3 million in 2026.
- The last three Net Cash Flow figures came in at -$40.3 million (Q1 2026), $137.8 million (Q4 2025), and -$32.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 664,983.53 |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -40.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.33 Mn |
| Mar 31, 2026 | -40.33 Mn |
| Dec 31, 2025 | 137.82 Mn |
| Dec 31, 2025 | 137.82 Mn |
| Sep 30, 2025 | -32.08 Mn |
| Sep 30, 2025 | -32.08 Mn |
| Jun 30, 2025 | -34.74 Mn |
| Jun 30, 2025 | -34.74 Mn |
| Mar 31, 2025 | -29.22 Mn |
| Mar 31, 2025 | -29.22 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Sep 30, 2024 | -21.35 Mn |
| Sep 30, 2024 | -21.35 Mn |
| Jun 30, 2024 | -26.70 Mn |
| Jun 30, 2024 | -26.70 Mn |
| Mar 31, 2024 | -39.73 Mn |
| Mar 31, 2024 | -39.73 Mn |
| Dec 31, 2023 | -60.16 Mn |
| Dec 31, 2023 | -60.16 Mn |